Candida colonisation in asymptomatic HIV patients attending a tertiary hospital in Benin City, Nigeria

Libyan Journal of Medicine

Volumn 8, Issue 1, 2013, Pages

  Esebelahie, Newton O ^a   Enweani, Ifeoma B ^a   Omoregie, Richard ^b  

^a NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Candida colonisation; HAART; HAART naive; Prevalence

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGE; AGED; ARTICLE; ASYMPTOMATIC DISEASE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNGAL COLONIZATION; FUNGUS ISOLATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NIGERIA; NONHUMAN; OUTCOME ASSESSMENT; PREVALENCE; RISK ASSESSMENT; BENIN; CANDIDA; CANDIDA COLONISATION; CASE CONTROL STUDY; CD4+ COUNTS; CLASSIFICATION; FECES; HAART-NAIVE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOUTH MUCOSA; RISK FACTOR; URINE;

CANDIDA COLONISATION; CD4+ COUNTS; HAART; HAART-NAIVE; PREVALENCE;

ADULT; AGE FACTORS; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BENIN; CANDIDA; CANDIDIASIS; CASE-CONTROL STUDIES; FECES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; RISK FACTORS; URINE; YOUNG ADULT;

EID: 84875359083     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v8i0.20322     Document Type: Article

References (31)

1. WHO. Laboratory manual for the diagnosis of fungal opportunistic infection in HIV/AIDS patients. New Delhi (India): WHO Regional Office for South-East Asia; 2009. p. 1-92.
2. Maplanka CC. AIDS: is there an answer to the global pandemic? The immune system in HIV infection and control. Viral Immunol. 2007; 20: 331-42.
3. Guattelli JC, Siliciano RF, Kuritzes DR, Richman DD. Human immunodeficiency virus. In: Clinical virology. 2nd ed. Washington, DC: ASM Press; 2002. p. 685-729.
4. UNAIDS (2008) Report on global AIDS epidemic [Downloaded 2010 August 14]. Available from: http://www.unaids.org/en/dataanalysis/knowyourepidemic/epidemiologypublications/ 2008reportontheglobalaidsepidemic/
5. Okolie MN, Eghafona NO, Omoregie R. Antihuman immunodeficiency virus agents. J Med Lab Sci. 2003; 12: 1-14.
6. Moazeni M, Haghmorad D, Mirshafie A. Opportunistic fungal infections in patients with HIV and AIDS. Review. J Chinese Clin Med. 2009; 4: 106-20.
7. Brooks GF, Carroll KC, Butel JS, Morse SA, Mietzner TA. AIDS and lentivirus. In: Weitz M, Lebowitz H, editors. Jawetz, Melnick & Adelberg's medical microbiology. 25th ed. New York: McGraw-Hill; 2010. p. 609-22.
8. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. Evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981; 305: 1425-31.
9. Masur H, Michelis M, Green J, Onorato I, Stouwe RA, Holzman RS, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med. 1981; 305: 1431-8.
10. Bharathi M, Rani AU. Pathogenic fungal isolates in sputum of HIV positive patients. J AIDS HIV Res. 2011; 3: 107-13.
11. Egusa H, Soysa NS, Ellepola AN, Yatani H, Samaranayake LP. Oral candidosis in HIV-infected patients. Curr HIV Res. 2008; 6: 485-99.
12. Alby K, Benneth RJ. Stress-induced phenotypic switching in Candida albicans. Mol Biol Cell. 2009; 20: 3178-91.
13. Samie A, Mashao MB. Diversity of respiratory yeast from HIV infected patients with tuberculosis, their drug resistances and biofilm formation. Afr J Microbiol Res. 2012; 6: 257-66.
14. Odunukwe N, Idigbe O, Kanki P, Adewale T, Onwujekwe D, Audu K, et al. Haematological and biochemical responses to treatment of HIV-1 infection with combination of nevirapine- stavudine-lamivudine in Lagos, Nigeria. Turkish J Haem. 2005; 22: 125-31.
15. Silvestri G, Feinberg MB. Turnover of lymphocytes and conceptual paradigms in HIV infection. J Clin Inves. 2003; 112: 821-3.
16. Torti C, Cologni G, Uccelli MC, Quiros-Roldan E, Imberti L, Airo P, et al. Immune correlates of virological responses in HIV positive patients after highly active antiretroviral therapy (HAART). Viral Immunol. 2004; 17: 279-86.
17. Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention and treatment. Lancet. 2006; 368: 489-504.
18. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med. 1996; 124: 633-42.
19. Costa CR, Cohen AJ, Fernandes OFL, Miranda KC, Passos XS, Souza LKH, et al. Asymptomatic oral carriage of Candida species in HIV-infected patients in the highly active antiretroviral therapy era. Rev Inst Med Trop S Paulo. 2006; 48: 257-61.
20. Yang YL, Lo HJ, Hung CC, Li Y. Effect of prolonged HAART on oral colonization with Candida and candidiasis. BMC Infect Dis. 2006; 20: 6-8.
21. Vazquez JA. Role of posaconazole in the management of oropharyngeal and oesophageal candidiasis. Ther Clin Risk Manag. 2007; 3: 533-42.
22. Njunda AL, Nisagha DS, Assob JCN, Kamga HLN, Teyim P. Candidiasis in HIV and AIDS patients attending the Nylon Health District Hospital in Douala, Cameroon. TAF Prev Med Bull. 2011; 10: 701-6.
23. Krause R, Schwab E, Bachhiesl D, Daxbock F, Wenisch C, Krejs GJ, et al. Role of Candida in antibiotic-associated diarrhoea. J Infect Dis. 2001; 184: 1065-9.
24. Paritpokee S, Hall G, Procop G. Rapid identification of yeast isolates using BD BBL™ CHROMagar™ Candida. A paper presented at the 105th General Meeting of the American Society for Microbiology. 2005; 1-2.
25. Forbes BA, Sahm DF, Weissfeld AS. Laboratory methods in basic mycology. In: Wilson L, Wurm E, editors. Bailey and Scott's diagnostic microbiology. 12th ed. Philadelphia: Mosby Elsevier; 2007. p. 629-717.
26. Schoots AG, Odds FC, Colebunders R, Ieven M, Goossens H. Cross-sectional study of oral Candida carriage in a human immunodeficiency virus (HIV) seropositive population: predisposing factors, epidemiology and antifungal susceptibility. Mycoses. 1998; 41: 203-11.
27. Hakim FT, Gress RE. Immunosenescence. Deficits in adaptive immunity in the elderly. Tissue Antigens. 2007; 70: 179-89.
28. Guy BS, Gonclaves J. Clinical data based optimal STI strategies for HIV: a reinforcement learning approach. Department of Engineering (Control group). University of Cambridge, UK; 2006. p. 5-15.
29. Enwuru CA, Ogunledun A, Idika N, Enwuru NV, Ogbonna F, Aniedobe M, et al. Fluconazole resistant opportunistic oropharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Afr Health Sci. 2008; 8: 142-8.
30. Wadhwa A, Ravinder K, Satish KA, Shyama J, Preena B. AIDSrelated opportunistic mycoses seen in a tertiary hospital in North India. J Med Microbiol. 2007; 56: 1101-6.
31. Yongabi KA, Mbacham WF, Nubia KK, Singh RM. Yeast strains isolated from HIV-seropositive patients in Cameroon and their sensitivity to extracts of eight plants. Afr J Microbiol Res. 2009; 3: 133-6.